Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Cook

Showing results (241-250 of 298) with videos related to

Pageof 30
Sort By:
The American Journal of Cardiology|September 1, 1991
Stability over time of variables measuring heart rate variability in normal subjectsR E Kleiger, J T Bigger, M S Bosner, et al.
The American Journal of Cardiology|November 25, 2000
Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research GroupA M Gotto, S J Boccuzzi, J R Cook, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 26, 2018
Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of <sup>18</sup>F-Fluoride Metabolic Flux Than with Measurement of <sup>18</sup>F-Fluoride PET/CT SUV?Gurdip K Azad, Musib Siddique, Benjamin Taylor, et al.
Journal of Medical Imaging and Radiation Oncology|July 24, 2009
Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancerR Venkitaraman, G J R Cook, D P Dearnaley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 11, 2008
Does magnetic resonance imaging of the spine have a role in the staging of prostate cancer?R Venkitaraman, G J R Cook, D P Dearnaley, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2018
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [<sup>18</sup>F] fluorodeoxyglucose and [<sup>18</sup>F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imagingGurdip K Azad, Benjamin P Taylor, Adrian Green, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2017
<sup>18</sup>F-Tetrafluoroborate, a PET Probe for Imaging Sodium/Iodide Symporter Expression: Whole-Body Biodistribution, Safety, and Radiation Dosimetry in Thyroid Cancer PatientsJim O'Doherty, Maite Jauregui-Osoro, Teresa Brothwood, et al.
Radiology|April 22, 2015
Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and PrognosisGary J R Cook, Mary E O'Brien, Muhammad Siddique, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 29, 2019
Exploratory radiomic features from integrated <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancerSerena Baiocco, Bert-Ram Sah, Andrew Mallia, et al.
The Journal of Biological Chemistry|December 20, 1996
Mouse macrophages carrying both subunits of the human interferon-gamma (IFN-gamma) receptor respond to human IFN-gamma but do not acquire full protection against viral cytopathic effectD Lembo, P Ricciardi-Castagnoli, G Alber, et al.
Pageof 30

Showing results (241-250 of 298) with videos related to

Sort By:
Pageof 30
The American Journal of Cardiology|September 1, 1991
Stability over time of variables measuring heart rate variability in normal subjectsR E Kleiger, J T Bigger, M S Bosner, et al.
The American Journal of Cardiology|November 25, 2000
Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research GroupA M Gotto, S J Boccuzzi, J R Cook, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 26, 2018
Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of <sup>18</sup>F-Fluoride Metabolic Flux Than with Measurement of <sup>18</sup>F-Fluoride PET/CT SUV?Gurdip K Azad, Musib Siddique, Benjamin Taylor, et al.
Journal of Medical Imaging and Radiation Oncology|July 24, 2009
Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancerR Venkitaraman, G J R Cook, D P Dearnaley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 11, 2008
Does magnetic resonance imaging of the spine have a role in the staging of prostate cancer?R Venkitaraman, G J R Cook, D P Dearnaley, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2018
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [<sup>18</sup>F] fluorodeoxyglucose and [<sup>18</sup>F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imagingGurdip K Azad, Benjamin P Taylor, Adrian Green, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2017
<sup>18</sup>F-Tetrafluoroborate, a PET Probe for Imaging Sodium/Iodide Symporter Expression: Whole-Body Biodistribution, Safety, and Radiation Dosimetry in Thyroid Cancer PatientsJim O'Doherty, Maite Jauregui-Osoro, Teresa Brothwood, et al.
Radiology|April 22, 2015
Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and PrognosisGary J R Cook, Mary E O'Brien, Muhammad Siddique, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 29, 2019
Exploratory radiomic features from integrated <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancerSerena Baiocco, Bert-Ram Sah, Andrew Mallia, et al.
The Journal of Biological Chemistry|December 20, 1996
Mouse macrophages carrying both subunits of the human interferon-gamma (IFN-gamma) receptor respond to human IFN-gamma but do not acquire full protection against viral cytopathic effectD Lembo, P Ricciardi-Castagnoli, G Alber, et al.
Pageof 30